Publikasi Scopus 2024 per tanggal 31 Agustus 2024 (707 artikel)

León A.G.-D.; Noyola-Pérez A.; Gil-Flores L.; Malhotra H.; Musteata V.; El-Beshlawy A.; Tadjoedin H.; Pavlovsky C.; Cortes J.
León, Andrés Gómez-De (55790392700); Noyola-Pérez, Andrés (57221227028); Gil-Flores, Lourdes (57910473900); Malhotra, Hemant (7004844632); Musteata, Vasile (7801671470); El-Beshlawy, Amal (6603278914); Tadjoedin, Hilman (57435336400); Pavlovsky, Carolina (24484790400); Cortes, Jorge (24400826900)
55790392700; 57221227028; 57910473900; 7004844632; 7801671470; 6603278914; 57435336400; 24484790400; 24400826900
Bringing global hematology research to the forefront
2024
Blood Advances
8
14
3607
3611
4
0
Department of Hematology, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India; N. Testemitanu State University of Medicine and Pharmacy, Discipline of Hematology, Institute of Oncology, Department of Hematology, Chisinau, Moldova; Cairo University, Cairo, Egypt; Department of Internal Medicine, Dharmais National Cancer Center, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Hematology and Research, Fundación de Lucha Contra la Leucemia, Buenos Aires, Argentina; Division of Hematology/Oncology, Department of Medicine, Georgia Cancer Center, Augusta University, Augusta, GA, United States
León A.G.-D., Department of Hematology, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Noyola-Pérez A., Department of Hematology, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Gil-Flores L., Department of Hematology, Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Malhotra H., Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India; Musteata V., N. Testemitanu State University of Medicine and Pharmacy, Discipline of Hematology, Institute of Oncology, Department of Hematology, Chisinau, Moldova; El-Beshlawy A., Cairo University, Cairo, Egypt; Tadjoedin H., Department of Internal Medicine, Dharmais National Cancer Center, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Pavlovsky C., Department of Hematology and Research, Fundación de Lucha Contra la Leucemia, Buenos Aires, Argentina; Cortes J., Division of Hematology/Oncology, Department of Medicine, Georgia Cancer Center, Augusta University, Augusta, GA, United States
[No abstract available]
anabolic agent; arsenic; arsenic trioxide; immunoglobulin G1; retinoic acid; steroid; acute lymphoblastic leukemia; acute myeloid leukemia; anemia; aplastic anemia; bibliometrics; chronic myeloid leukemia; gene therapy; government; hematologic disease; hematologic malignancy; hematology; hematopoietic cell; hematuria; hemoglobinopathy; human; infection; journal impact factor; language ability; Letter; myelodysplastic syndrome; omics; peer review; promyelocytic leukemia; publication; research; total quality management; training; workload
American Society of Hematology
24739529
38739717
Letter
Q1
3070
589